YBL059W Antibody

Shipped with Ice Packs
In Stock

Description

Antibody Structure and Function

Antibodies (immunoglobulins) are Y-shaped proteins composed of two heavy chains and two light chains, forming antigen-binding (Fab) and effector (Fc) regions . The Fab fragment contains variable domains that recognize specific epitopes, while the Fc region mediates immune responses. Antibodies like those targeting YBL059W would theoretically bind to the gene’s protein product, aiding in detection, neutralization, or immunoprecipitation .

YBL059W Gene and Protein Context

  • Gene Expression: Transcriptional profiling reveals YBL059W is upregulated under stress conditions, including sorbic acid adaptation and MSN2/4-dependent pathways .

  • Protein Features: The encoded protein lacks annotated functional domains, suggesting it may play a niche role in yeast physiology.

Relevant Antibody Development Insights

Research on RNA-binding antibodies provides a framework for understanding potential YBL059W-targeting antibodies:

  • Fab Fragment Engineering: A study on YBL059W branched RNA demonstrated that synthetic Fab libraries can generate high-affinity RNA binders (e.g., Fab BRG with Kd = 21 ± 3 nM) .

  • Epitope Profiling: Computational tools like SPACE2 enable precise clustering of antibodies by epitope engagement, critical for validating YBL059W-specific binding .

Gene Expression Profile

GeneORF NameBiological ProcessWild Type (x-fold)war1Δ (x-fold)msn2Δ msn4Δ (x-fold)
YBL059WYCL040WUnknown2.832.821.22

Antibody Binding Characteristics

AntibodyTargetBinding Affinity (Kd)Specificity
Fab BRGYBL059W Branched RNA21 ± 3 nMRNA-specific
Fab BRK1YBL059W Branched RNA>500 nMCross-reactive

Future Directions

  • Protein Characterization: Functional studies are needed to elucidate the role of YBL059W in yeast.

  • Antibody Validation: Confirming YBL059W-specific binding requires orthogonal assays (e.g., Western blot, immunoprecipitation).

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YBL059W; YBL0508; YBL0516; Uncharacterized protein YBL059W
Target Names
YBL059W
Uniprot No.

Target Background

Database Links

KEGG: sce:YBL059W

STRING: 4932.YBL059W

Subcellular Location
Mitochondrion membrane; Single-pass membrane protein.

Q&A

What is YBL059W and why is it significant in research?

YBL059W is a gene from Saccharomyces cerevisiae (baker's yeast) that encodes a putative protein of unknown function. The protein has attracted research interest because it has been detected in highly purified mitochondria in high-throughput studies, suggesting a potential role in mitochondrial function . It has a paralog, YER093C-A, that arose from whole genome duplication, which may indicate evolutionary significance . The development of antibodies against YBL059W and its RNA products has enabled more detailed investigations into its cellular functions and has applications in RNA biology research.

How are antibodies against YBL059W typically generated?

Antibodies against YBL059W are typically generated through recombinant technology. For example, the Anti-ssRNA sequence-specific antibody BRG (5E08) recognizes RNA from the YBL059W gene . These antibodies can be developed using display technologies with either natural immune repertoires or minimalist repertoires with designed diversity . For RNA targets like YBL059W, research has demonstrated that minimalist libraries within the Fab 4D5 framework can yield Fabs that bind RNAs with high affinity and specificity .

What formats of YBL059W antibodies are available for research?

YBL059W-specific antibodies are available in multiple formats to suit different experimental needs. These include:

  • Human Fab fragments with His-tags (for purification and detection purposes)

  • Human IgG1 (standard format and Fc Silent™ versions for reduced Fc receptor binding)

  • Mouse IgG1 (commonly used in laboratory applications)

  • Rabbit IgG (offering different species reactivity profiles)

  • Rat IgG2b (standard and Fc Silent™ versions)

These diverse formats allow researchers to select the most appropriate antibody configuration based on their specific experimental requirements, detection systems, and host species considerations.

What is the binding specificity of the BRG (5E08) antibody for YBL059W RNA?

The BRG (5E08) antibody demonstrates high specificity for RNA from the YBL059W gene. In binding studies, Fab BRG bound to YBL059W branched RNA with high affinity (KD = 21 ± 3 nM) . Importantly, specificity tests showed that BRG exhibits RNA-specific binding, as it did not bind to a deoxynucleotide version of the R strand (Deoxy R), demonstrating its specificity for RNA rather than DNA with the same sequence . This RNA-specific recognition makes it a valuable tool for studying RNA biology.

What is the epitope recognized by the BRG antibody on YBL059W RNA?

Epitope mapping studies revealed that Fab BRG binds specifically to the R strand of YBL059W branched RNA. When researchers tested BRG's ability to bind non-branched oligonucleotide strands (L and R) corresponding to sequences found in YBL059W branched RNA, BRG showed no detectable binding to the L strand but maintained similar affinity to the R strand as it had for the complete branched RNA . This suggests that the entire binding epitope resides solely within the R strand of the YBL059W RNA .

How can I use YBL059W antibodies for RNA-protein interaction studies?

For RNA-protein interaction studies with YBL059W antibodies, researchers can implement several methodologies:

  • RNA Immunoprecipitation (RIP): Utilize the BRG (5E08) antibody to capture YBL059W RNA and its associated proteins. This involves:

    • Crosslinking RNA-protein complexes in cells

    • Cell lysis under non-denaturing conditions

    • Immunoprecipitation with the BRG antibody

    • RNA extraction and analysis by RT-PCR or sequencing

  • In vitro binding assays: These can be performed by immobilizing biotinylated RNA on streptavidin surfaces and detecting binding with the BRG antibody, similar to the approach used in the original characterization studies where strand L of the branched RNA was biotinylated on the 3'-end during solid-phase oligonucleotide synthesis .

What detection methods work best with YBL059W antibodies?

Several detection methods have proven effective with YBL059W antibodies:

  • DELFIA (Dissociation-Enhanced Lanthanide Fluorescence Immunoassay): This time-resolved fluorescence (TRF) assay chemistry provides high sensitivity with inherently low fluorescent background, making it particularly suitable for detecting specific, high-affinity antibodies like those against YBL059W . The lanthanide chelates used in DELFIA assays have long fluorescence decay times and large Stokes shifts, allowing delayed signal measurement at wavelengths with little background interference .

  • Filter binding assays: For direct RNA binding studies, nitrocellulose filter binding assays have been used successfully to measure the affinity of antibodies like BRG to their RNA targets .

  • Immunofluorescence: For localization studies, especially when examining the mitochondrial localization of YBL059W, standard immunofluorescence protocols with appropriate controls can be employed .

How should I optimize sample preparation for YBL059W antibody experiments?

Optimal sample preparation for YBL059W antibody experiments depends on the specific application but generally includes:

  • For RNA binding studies:

    • Ensure RNA quality by using RNase-free conditions

    • Consider using fresh preparations of RNA rather than stored samples

    • Include appropriate controls (such as deoxynucleotide versions) to confirm RNA specificity

  • For protein detection:

    • When coating assay plates with antigen, use 0.5-1.0 μg/well of purified or partially purified antigen

    • For limited antigen availability, consider using labeled antigen approaches as described in DELFIA assay configurations

    • For assays requiring polyclonal antibody, minimize usage by employing approaches that require only 50-100 ng/well

What factors might affect YBL059W antibody expression and quality?

Several factors can impact the expression and quality of YBL059W antibodies:

  • Positively charged residues in CDR loops: Studies have shown that significant numbers of positively charged residues in complementarity-determining region (CDR) loops can negatively impact Fab expression . For example, BRK1 and BRK2 Fabs, which had 2 and 4 positively charged residues in their CDR loops respectively, showed poor expression yields in E. coli (< 1 mg/L), with BRK2 giving only trace yield .

  • Expression system selection: Different antibody formats may require specific expression systems. For optimal yield and functionality, researchers should consider whether bacterial, mammalian, or other expression systems are most appropriate for their specific antibody format .

  • Purification approach: The presence of tags (such as His-tags on Fab fragments) can facilitate purification but may potentially affect binding properties in some applications and should be considered when interpreting results .

How can I reconcile contradictory localization data for YBL059W?

The localization data for YBL059W shows some variability across different experimental conditions. To reconcile contradictory data:

  • Consider condition-specific localization: The localization data shows that while YBL059W is predominantly mitochondrial (with probability scores ranging from 0.43 to 0.87), it also shows significant cytoplasmic localization under some conditions (scores from 0.07 to 0.82) . This suggests condition-dependent localization or function.

  • Evaluate experimental conditions: Different stress conditions (RAP, HU, AF) or genetic backgrounds (rpd3Δ) can alter YBL059W localization patterns . When comparing results across studies, carefully consider the experimental conditions used.

  • Use multiple detection methods: Combining antibody-based detection with other approaches such as fluorescent protein tagging or RNA FISH can provide complementary data to validate localization findings.

  • Consider time-course experiments: The localization data shows variability across time points (e.g., RAP60 through RAP700), suggesting that the protein may change localization over time or in response to cellular conditions .

How can YBL059W antibodies be used as tools for RNA crystallography?

YBL059W antibodies, particularly Fab fragments like BRG, can serve as valuable chaperones for RNA crystallization:

  • Co-crystallization approach: Fab fragments can be used as crystallization chaperones by forming stable complexes with RNA targets. This has been established as proof-of-principle for Fabs binding RNAs with high affinity and specificity .

  • Advantages of the approach: Fabs like BRG that bind RNA with high affinity (KD = 21 ± 3 nM) can stabilize RNA structures, provide additional crystal contacts, and reduce conformational heterogeneity of the RNA, all of which can improve crystallization outcomes .

  • Sample preparation: For co-crystallization experiments:

    • Form the RNA-Fab complex by mixing purified components

    • Purify the complex using size exclusion chromatography

    • Screen crystallization conditions optimized for RNA-protein complexes

    • Include controls with RNA alone to demonstrate the benefit of the chaperone

What approaches can be used to study YBL059W RNA interactions with other cellular components?

Several approaches can be employed to study YBL059W RNA interactions:

  • Competitive binding assays: Using BRG antibody and potential protein partners to identify competition for binding sites on the RNA. The specific recognition of the R strand by BRG makes it particularly useful for mapping interaction sites .

  • Protection assays: The BRG antibody can be used to protect specific regions of the RNA from nuclease digestion or chemical modification, helping to map interaction sites for other factors.

  • Pull-down experiments: Leveraging the different available formats of YBL059W antibodies (human, mouse, rabbit, rat) allows flexibility in designing complex pull-down experiments with multiple antibodies without cross-reactivity concerns .

  • Debranching enzyme assays: Since YBL059W RNA forms branched structures that are substrates for debranching enzymes like Dbr1, antibodies like BRG that bind to specific regions might inhibit the debranching reaction, providing insight into the structural requirements for this process .

How should researchers interpret changes in YBL059W localization under different experimental conditions?

When interpreting changes in YBL059W localization:

  • Baseline understanding: Under standard conditions (WT), YBL059W shows predominantly mitochondrial localization with some cytoplasmic presence .

  • Stress responses: Under rapamycin treatment (RAP series), YBL059W shows initial decreases in mitochondrial localization (RAP60-RAP140) followed by increases (RAP220-RAP300), and then even higher mitochondrial association at later timepoints (RAP460-RAP700) . This suggests a dynamic response to TOR pathway inhibition.

  • Cell cycle effects: During hydroxyurea treatment (HU series), which causes S-phase arrest, YBL059W shows a marked shift from mitochondrial to cytoplasmic localization (mitochondrial scores dropping from 0.62 in WT1 to 0.15-0.07 in HU80-HU160, while cytoplasmic scores increase from 0.26 to 0.71-0.82) . This suggests cell cycle-dependent regulation of localization.

  • Genetic background effects: In rpd3Δ strains (lacking the histone deacetylase Rpd3), YBL059W shows reduced mitochondrial localization and increased association with endosomes and peroxisomes , suggesting that chromatin regulation may indirectly impact YBL059W localization.

What methodological considerations are important when analyzing YBL059W antibody binding data?

When analyzing YBL059W antibody binding data:

  • Binding specificity controls: Always include appropriate controls such as testing binding to deoxynucleotide versions of the RNA (as done with BRG and BRK1 Fabs) to confirm RNA specificity .

  • Format considerations: Different antibody formats (Fab vs. IgG, or human vs. mouse versions) may exhibit different binding characteristics or background levels in certain assays . When comparing data across formats, consider inherent differences in size, valency, and potential for non-specific interactions.

  • Quantitative analysis: For binding affinity measurements, ensure proper fitting of binding curves and reporting of KD values with appropriate error measurements. The reported KD of 21 ± 3 nM for BRG binding to YBL059W branched RNA provides a good example of data reporting standards .

  • Signal detection optimization: When using lanthanide-based detection systems like DELFIA, leverage the benefits of time-resolved fluorescence to improve signal-to-noise ratios . The large Stokes shift and long fluorescence decay times of lanthanide chelates allow delayed signal measurement at wavelengths with minimal background interference.

How might YBL059W antibodies contribute to understanding RNA processing and mitochondrial function?

YBL059W antibodies represent valuable tools for advancing our understanding of RNA processing and mitochondrial function:

  • RNA branch point recognition: Since the BRG antibody specifically recognizes the R strand of YBL059W branched RNA , it could help elucidate the structural features of RNA branch points and their recognition by processing machinery.

  • Mitochondrial RNA processing: Given the strong mitochondrial localization of YBL059W , antibodies against this target could help reveal connections between RNA processing and mitochondrial function.

  • Stress-responsive RNA metabolism: The dynamic changes in YBL059W localization under different stress conditions suggest it may play a role in stress-responsive RNA metabolism. Antibodies could help track these changes and identify interacting partners under different conditions.

  • Evolutionary conservation: Studying the interaction of YBL059W antibodies with the paralogous gene product YER093C-A could provide insights into the evolution of RNA processing mechanisms following genome duplication events.

What emerging technologies might enhance the utility of YBL059W antibodies?

Several emerging technologies could enhance YBL059W antibody applications:

  • CRISPR-based tagging: Combining CRISPR-mediated endogenous tagging with antibody-based detection could provide more physiologically relevant insights into YBL059W function.

  • Single-molecule imaging: Using fluorescently labeled YBL059W antibody fragments to track RNA dynamics in living cells could reveal previously unknown aspects of RNA trafficking and processing.

  • Cryo-EM studies: Beyond crystallography, YBL059W antibodies could serve as fiducial markers for cryo-electron microscopy studies of large RNA-protein complexes.

  • Synthetic biology applications: As noted in the literature, "Antibodies that bind RNA represent an unrealized source of reagents for synthetic biology and for characterizing cellular transcriptomes" . YBL059W antibodies could contribute to the development of new synthetic biology tools for manipulating RNA processing and function.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.